Demant A/S (OTCMKTS:WILYY – Get Free Report) and Innovative Eyewear (NASDAQ:LUCY – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, profitability, institutional ownership and analyst recommendations.
Insider & Institutional Ownership
1.0% of Innovative Eyewear shares are owned by institutional investors. 1.7% of Innovative Eyewear shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Profitability
This table compares Demant A/S and Innovative Eyewear’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Demant A/S | N/A | N/A | N/A |
| Innovative Eyewear | -272.42% | -83.37% | -76.02% |
Analyst Recommendations
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Demant A/S | 0 | 1 | 0 | 1 | 3.00 |
| Innovative Eyewear | 1 | 1 | 0 | 0 | 1.50 |
Earnings & Valuation
This table compares Demant A/S and Innovative Eyewear”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Demant A/S | $3.48 billion | 2.40 | $233.91 million | N/A | N/A |
| Innovative Eyewear | $2.66 million | 2.18 | -$7.59 million | ($1.69) | -0.54 |
Demant A/S has higher revenue and earnings than Innovative Eyewear.
Volatility & Risk
Demant A/S has a beta of 1.2, indicating that its share price is 20% more volatile than the S&P 500. Comparatively, Innovative Eyewear has a beta of 2.66, indicating that its share price is 166% more volatile than the S&P 500.
Summary
Demant A/S beats Innovative Eyewear on 8 of the 11 factors compared between the two stocks.
About Demant A/S
Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally. It operates through two segments: Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services. The Communications segment provides headsets and solutions for the professional call centers, office markets, and gaming markets under the EPOS brand name. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.
About Innovative Eyewear
Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. In addition, the company launches an application, Lucyd app for iOS/Android users. It sells its products through various e-commerce, and retail store and distribution channels. Innovative Eyewear, Inc. has a license agreement with Lucyd Ltd. The company was incorporated in 2019 and is headquartered in North Miami, Florida. Innovative Eyewear, Inc. is a subsidiary of Lucyd Ltd.
Receive News & Ratings for Demant A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Demant A/S and related companies with MarketBeat.com's FREE daily email newsletter.
